Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Key Record Dates Identifier: NCT03807479
Brief Title: A Study in Patients With Chronic Leukemia, Where Previous Therapy Failed, and Who Will be Treated With Ponatinib as Second Line Therapy (PONS). (PONS)

First Submitted : November 7, 2018
First Submitted that Met QC Criteria : January 14, 2019
First Posted : January 17, 2019

Last Update Submitted that Met QC Criteria : October 10, 2019
Last Update Posted : October 11, 2019